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To the Editor: Lung cancer is the most common cause of cancer-related 
mortality worldwide for men and women, causing approximately 1.2 
million deaths per year.1 The absolute and relative frequencies of lung 
cancer have risen dramatically1 and in South Africa account for 17% 
of all cancer deaths.2 We found that adenocarcinoma is now the most 
common histological subtype of primary lung cancer diagnosed in 
the Western Cape and that almost 90% of all patients with non-small 
cell lung cancer have advanced local or metastatic disease at the time 
of diagnosis.
‘Lung cancer’ denotes cancer arising in the airways and pulmonary 
parenchyma. Its histopathological designation is based on the World 
Health Organization classification system, with 4 cell types responsible 
for most deaths: adenocarcinoma (including bronchoalveolar 
carcinoma), squamous cell carcinoma, large cell (undifferentiated) 
carcinoma and small cell carcinoma.3 Carcinoid tumours and other 
rare cell types complete the list of  cell types. An interesting 
phenomenon in the developed world over the last two decades 
has been the relative increase in the diagnosis of adenocarcinoma 
which has replaced squamous cell carcinoma as the most frequent 
histological subtype.4 Many explanations for this well-documented 
phenomenon have been suggested.
There are few current South African data regarding the relative 
incidence of the various cell types. The latest National Cancer 
Registry (NCR) report is from 2001, and contains no data on the 
relative incidence of the lung cancer cell types.5 Moreover, published 
and unpublished data from the 1980s suggested that more than 
50 - 60% of all lung cancers were squamous cell carcinomas.6 As we 
found no published study over the last two decades that addresses 
this issue, we report the relative figures for a two-year period 
observed in a tertiary referral centre in Cape Town. We postulate that 
adenocarcinoma could be the most frequently observed variant, and 
provide an overview of the staging of all the cases of non-small cell 
and small cell lung cancer patients included.
We used our local lung cancer registry that is updated weekly 
during a combined multidisciplinary oncology meeting at Tygerberg 
Academic Hospital to identify all cases of primary lung cancer 
presented from January 2008 - December 2009 for potential curative 
or palliative treatment. We retrospectively collected data on all 
patients who had a tissue diagnosis of primary lung cancer and who 
underwent at least a staging computed tomography (CT) scan as 
per hospital protocol. Lung cancer was staged according to the 2002 
Union Internationale Contre le Cancer staging system at the time of 
the study. The Health Research Ethics Committee of Stellenbosch 
University approved the study (project number N10/03/096) and the 
Chief Medical Superintendent of Tygerberg Academic Hospital gave 
permission for the anonymous collection of data.
We identified 507 cases (patient ages 59.7 ±10.4 years, 323 male) of 
primary lung cancer that fulfilled the inclusion criteria; 430 (84.8%) 
had non-small cell lung cancer, and the relative contributions were: 
adenocarcinoma 215 (42.4%), squamous cell carcinoma 113 (22.3%), 
large cell carcinoma 98 (19.3%) and bronchoalveolar carcinoma 4 
(0.8%). Additionally, 63 (12.4%) had small cell lung cancer, and 14 
(2.8%) were diagnosed with other forms of lung cancer.
Only 28 patients had early stage non-small cell lung cancer (stages I 
(N=13) and II (N=15)); 19 were staged as IIIA and 81 as IIIB, respectively. 
Most patients (302, 69.9%) with non-small cell lung cancer had metastatic 
disease (stage IV) at the outset. Among the patients with small cell lung 
cancer, 12 had limited disease while 51 had extensive disease.
We believe that this is the first study providing evidence from South 
Africa that adenocarcinoma has overtaken squamous cell carcinoma 
as the most frequently diagnosed subtype of primary lung cancer. We 
also found that 89.1% of patients with non-small cell lung cancer had 
advanced disease at presentation (stage IIIB or stage IV disease).
Although South Africa has lagged in the shift from squamous 
cell carcinoma to adenocarcinoma, the explanation for the shift is 
probably the same as that suggested for Europe and the United States. 
Implicated factors include technical aspects (e.g. the routine use of 
immunohistochemistry or immunocytochemistry in practically all 
cases) and smoking-related explanations (e.g. decrease in nicotine 
and tar delivery of cigarettes with compensatory deeper inhalation, 
composition of cigarette tobacco blends, and use of filter tips).7-9
There are limitations in our study. Apart from its retrospective 
nature, our institution provides a tertiary service to a population 
of approximately 1.5 million, comprising coloureds (52.3%), blacks 
(27.9%), and whites (18.2%), that may not be representative of 
South Africa as a whole, and it is unclear whether our findings can 
be extrapolated to rural southern Africa. Similar studies from other 
areas as well as an updated national registry are urgently needed.
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